MRI-Based Neurodevelopmental Risk Stratification in Infants With White Matter Injury
Multicenter Study for Developing an MRI Assessment System for Neurodevelopmental Risk Stratification in Infants With White Matter Injury
The goal of this observational study is to develop and evaluate an MRI-based assessment system for predicting neurodevelopmental outcomes in infants with punctate white matter lesions (PWML). This is a multicenter, bidirectional cohort study that includes both a retrospective cohort identified from existing clinical and imaging databases and a prospective cohort of consecutively enrolled participants. The study aims to better understand how MRI findings are associated with later developmental outcomes and to identify imaging markers that may help stratify developmental risk.
The main questions it aims to answer are:
- Which MRI features are associated with adverse neurodevelopmental outcomes in infants with PWML?
- Can MRI-based quantitative assessment methods provide early risk stratification for neurodevelopmental outcomes in infants with PWML?
Participants with PWML diagnosed by brain MRI will be followed and evaluated for neurodevelopmental outcomes. Researchers will analyze clinical information and MRI findings collected from participants to develop and validate prediction models. Participants will:
- undergo brain MRI examinations according to clinical protocols;
- receive standardized neurodevelopmental assessments during follow-up;
- have their MRI findings and developmental outcomes analyzed to identify factors associated with later neurodevelopment.
연구 개요
상태
연구 유형
등록 (추정된)
연락처 및 위치
연구 연락처
- 이름: Jian Yang
- 전화번호: +86 18991232396
- 이메일: yj1118@mail.xjtu.edu.cn
연구 장소
-
-
-
Ankang, 중국
- Ankang Central Hospital
-
연락하다:
- Yukun Liang
- 전화번호: +86 0915-3284060
- 이메일: 452838744@qq.com
-
Chengdu, 중국
- Sichuan Provincial Maternity and Child Health Care Hospital
-
연락하다:
- Min Kang
- 전화번호: +86 28 8773 8249
- 이메일: 1073297610@qq.com
-
Hangzhou, 중국
- Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University
-
연락하다:
- Haibin Wang
- 전화번호: +86 0571-56005600
- 이메일: haibinw0818@163.com
-
Lanzhou, 중국
- Gansu Province Maternity and Child Health Hospital
-
연락하다:
- Dalin Zhu
- 전화번호: +86 0931-5188888
- 이메일: zdlldz@126.com
-
Qinghai, 중국
- Qinghai Red Cross Hospital
-
연락하다:
- Zhao Feng
- 전화번호: +86 0971-8290706
- 이메일: feng001zhao@126.com
-
Shanghai, 중국
- Shanghai Children's Hospital, School of Medicine, Shanghai Jiaotong University
-
연락하다:
- Haoxiang Jiang
- 전화번호: +86 021-5297601
- 이메일: wyshzl@126.com
-
Shijiazhuang, 중국
- Hebei Children's Hospital
-
연락하다:
- Shujing Li
- 전화번호: +86 0311-85911234
- 이메일: lishujing1976@126.com
-
Suzhou, 중국
- Children's Hospital of Soochow University
-
연락하다:
- WanLiang Guo
- 전화번호: +86 0512-80693588
- 이메일: gwlsuzhou@163.com
-
Xianyang, 중국
- The Second Affiliated Hospital of Shaanxi University of Chinese Medicine
-
연락하다:
- Changyi Guo
- 전화번호: +86 029-33579191
- 이메일: 344952556@qq.com
-
-
Shaanxi
-
Xi'an, Shaanxi, 중국, 710061
- First Affiliated Hospital of Xi'an Jiaotong University
-
연락하다:
- Jian Yang
- 전화번호: +86 18991232396
- 이메일: yj1118@mail.xjtu.edu.cn
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
This study includes infants with punctate white matter lesions (PWML) diagnosed by conventional brain MRI. Eligible participants are infants born at a gestational age of ≥32 weeks and <42 weeks who underwent MRI examination at a corrected gestational age of ≤45 weeks. This multicenter observational cohort study includes retrospective and prospective participants. Clinical information, MRI findings, and longitudinal neurodevelopmental outcomes will be collected to investigate MRI-based assessment methods and predictors of adverse neurodevelopmental outcomes.
설명
Inclusion Criteria:
- Gestational age ≥32 weeks and <42 weeks at birth.
- Brain MRI performed at a corrected gestational age ≤45 weeks.
- Punctate white matter lesions (PWML) diagnosed by conventional brain MRI.
Exclusion Criteria:
- Other confirmed brain lesions, such as severe intracranial hemorrhage or cerebral infarction.
- Congenital developmental abnormalities.
- Confirmed genetic or metabolic diseases.
- Conditions that severely affect MRI assessment or neurological/developmental evaluation.
- Inability to complete required MRI assessment or follow-up evaluation.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: COHORT
- 시간 관점: OTHER
코호트 및 개입
그룹/코호트 |
|---|
|
Moderate-to-Late Preterm Infants with PWML
This cohort includes infants born at 32 to less than 37 weeks of gestation with punctate white matter lesions diagnosed by brain MRI. Participants will undergo clinical data collection, MRI assessment, and longitudinal neurodevelopmental follow-up to evaluate developmental outcomes. |
|
Term Infants with PWML
This cohort includes infants born at 37 to less than 42 weeks of gestation with punctate white matter lesions diagnosed by brain MRI. Participants will undergo clinical data collection, MRI assessment, and longitudinal neurodevelopmental follow-up to evaluate developmental outcome |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Adverse neurodevelopmental outcome at 2 Years
기간: At 2 Years of Age
|
The percentage of participants with an adverse neurodevelopmental outcome at 2 years of age will be assessed using standardized developmental assessment tools, including the Bayley Scales of Infant and Toddler Development, Second or Fourth Edition (Bayley-II or Bayley-IV), Gesell Developmental Schedules, or the Children's Neuropsychological Development Scale, according to the assessment tool and version used at each participating center. Adverse neurodevelopmental outcome will be defined according to predefined criteria based on developmental assessment scores in the cognitive, motor, and language domains, when available. MRI-derived measures will be analyzed to characterize the extent and pattern of white matter injury and to evaluate their prognostic value for subsequent neurodevelopmental outcomes. These measures will include lesion burden, semiquantitative MRI metrics, DTI-based measures, and structural disconnection measures derived from multimodal MRI. |
At 2 Years of Age
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Cognitive Developmental Outcome
기간: At scheduled neurodevelopmental follow-up assessments at 6 months, 1 year, 2 years, and 3-5 years of age
|
Cognitive development will be assessed using standardized developmental assessment tools, including the Bayley Scales of Infant and Toddler Development, Second or Fourth Edition (Bayley-II or Bayley-IV), Gesell Developmental Schedules, or the Children's Neuropsychological Development Scale, according to the assessment tool and version used at each participating center. Cognitive impairment will be defined according to predefined score thresholds.The prognostic value of MRI-derived metrics for cognitive impairment will be evaluated. These metrics will include PWML burden, lesion distribution, semi-quantitative metrics, DTI-based measures, and structural disconnection measures. |
At scheduled neurodevelopmental follow-up assessments at 6 months, 1 year, 2 years, and 3-5 years of age
|
|
Motor Developmental Outcome
기간: At scheduled neurodevelopmental follow-up assessments at 6 months, 1 year, 2 years, and 3-5 years of age
|
Motor development will be assessed using standardized developmental assessment tools, including the Bayley Scales of Infant and Toddler Development, Second or Fourth Edition (Bayley-II or Bayley-IV), Gesell Developmental Schedules, or the Children's Neuropsychological Development Scale, according to the assessment tool and version used at each participating center. Motor impairment will be defined according to predefined score thresholds. The prognostic value of MRI-derived metrics for motor impairment will be evaluated. These metrics will include PWML burden, lesion distribution, semi-quantitative metrics, DTI-based measures, and structural disconnection measures. |
At scheduled neurodevelopmental follow-up assessments at 6 months, 1 year, 2 years, and 3-5 years of age
|
|
Language Developmental Outcome
기간: At scheduled neurodevelopmental follow-up assessments at 6 months, 1 year, 2 years, and 3-5 years of age
|
Language development will be assessed using standardized developmental assessment tools, including the Bayley Scales of Infant and Toddler Development, Fourth Edition (Bayley-IV), Gesell Developmental Schedules, or the Children's Neuropsychological Development Scale, when available and according to the assessment tool and version used at each participating center. Language impairment will be defined according to predefined score thresholds. The prognostic value of MRI-derived metrics for language impairment will be evaluated. These metrics will include PWML burden, lesion distribution, semi-quantitative metrics, DTI-based measures, and structural disconnection measures. |
At scheduled neurodevelopmental follow-up assessments at 6 months, 1 year, 2 years, and 3-5 years of age
|
공동 작업자 및 조사자
간행물 및 유용한 링크
일반 간행물
- Wisnowski JL, Wintermark P, Bonifacio SL, Smyser CD, Barkovich AJ, Edwards AD, de Vries LS, Inder TE, Chau V; Newborn Brain Society Guidelines and Publications Committee. Neuroimaging in the term newborn with neonatal encephalopathy. Semin Fetal Neonatal Med. 2021 Oct;26(5):101304. doi: 10.1016/j.siny.2021.101304. Epub 2021 Oct 29.
- Kennedy E, Guo T, Williams S, Selvanathan T, Alsweiler JM, Bloomfield FH, Battin M, Dubowitz D, Miller SP, Morgan C, Perry D, Stott NS, Harding JE; MR DIAMOND and MoPED Study Groups. Punctate White Matter Abnormality in Moderate-to-Late Preterm Infants. Ann Neurol. 2025 Aug;98(2):329-340. doi: 10.1002/ana.27261. Epub 2025 Jun 9.
- Mitha A, Chen R, Razaz N, Johansson S, Stephansson O, Altman M, Bolk J. Neurological development in children born moderately or late preterm: national cohort study. BMJ. 2024 Jan 24;384:e075630. doi: 10.1136/bmj-2023-075630.
- Cayam-Rand D, Guo T, Grunau RE, Benavente-Fernandez I, Synnes A, Chau V, Branson H, Latal B, McQuillen P, Miller SP. Predicting developmental outcomes in preterm infants: A simple white matter injury imaging rule. Neurology. 2019 Sep 24;93(13):e1231-e1240. doi: 10.1212/WNL.0000000000008172. Epub 2019 Aug 29.
- Guo T, Duerden EG, Adams E, Chau V, Branson HM, Chakravarty MM, Poskitt KJ, Synnes A, Grunau RE, Miller SP. Quantitative assessment of white matter injury in preterm neonates: Association with outcomes. Neurology. 2017 Feb 14;88(7):614-622. doi: 10.1212/WNL.0000000000003606. Epub 2017 Jan 18.
- Hayman M, van Wezel-Meijler G, van Straaten H, Brilstra E, Groenendaal F, de Vries LS. Punctate white-matter lesions in the full-term newborn: Underlying aetiology and outcome. Eur J Paediatr Neurol. 2019 Mar;23(2):280-287. doi: 10.1016/j.ejpn.2019.01.005. Epub 2019 Jan 26.
- Inder TE, Volpe JJ, Anderson PJ. Defining the Neurologic Consequences of Preterm Birth. N Engl J Med. 2023 Aug 3;389(5):441-453. doi: 10.1056/NEJMra2303347. No abstract available.
- Rees P, Callan C, Chadda KR, Vaal M, Diviney J, Sabti S, Harnden F, Gardiner J, Battersby C, Gale C, Sutcliffe A. Preterm Brain Injury and Neurodevelopmental Outcomes: A Meta-analysis. Pediatrics. 2022 Dec 1;150(6):e2022057442. doi: 10.1542/peds.2022-057442.
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- MR-61-26-042984
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .